Comparing the Effectiveness of Cognitive-Behavioral Group Therapy and Mindfulness-Based Cognitive Therapy on Improving Quality of Life and Increasing CD4 Index in HIV/AIDS Patients Under Treatment in Ahvaz City, Iran

Molavi, Shahla; Seraj Khorrami, Naser; Ehteshamzadeh, Parvin; Sayyah, Mehdi

doi:10.29252/mejds.0.0.139

Volume 12 - Articles-1401 MEJDS (2022) 12: 250 | Back to browse issues page

‎ 10.29252/mejds.0.0.139

‎ 20.1001.1.23222840.1399.0.0.147.6

Mendeley

Zotero

RefWorks

Molavi S, Seraj Khorrami N, Ehteshamzadeh P, Sayyah M. Comparing the Effectiveness of Cognitive-Behavioral Group Therapy and Mindfulness-Based Cognitive Therapy on Improving Quality of Life and Increasing CD4 Index in HIV/AIDS Patients Under Treatment in Ahvaz City, Iran. MEJDS 2022; 12 :250-250
URL: http://jdisabilstud.org/article-1-1809-en.html

Comparing the Effectiveness of Cognitive-Behavioral Group Therapy and Mindfulness-Based Cognitive Therapy on Improving Quality of Life and Increasing CD4 Index in HIV/AIDS Patients Under Treatment in Ahvaz City, Iran

Shahla Molavi¹

, Naser Seraj Khorrami ^*²

, Parvin Ehteshamzadeh³

, Mehdi Sayyah⁴

1- Department of Health Psychology, Khorramshahr-Persian Gulf International Branch, Islamic Azad University, Khorramshahr, Iran
2- Department of Psychology, Dezful Branch, Islamic Azad University, Dezful, Iran
3- Department of Psychology, Ahvaz Branch, Islamic Azad University, Ahvaz, Iran
4- Ahvaz Jundishaur University of Medical Sciences, Ahvaz, Iran

Abstract: (1815 Views)

Abstract
Background & Objective: One of the chronic diseases is acquired immunodeficiency syndrome (AIDS), an acquired immunodeficiency syndrome. It is a chronic and progressive disease that affects patients' quality of life. The disease has a slow course of development and weakens the immune system. Human immunodeficiency virus (HIV) is the causative agent of AIDS. It is a group of retroviruses that invade and disrupt the cells of the immune system and cause fatal infections. Human immunodeficiency viruses are HIV1 and HIV2, which are cytopathic viruses. HIV–infected people develop symptoms such as fever, sweating, tremor, lymph node swelling, weakness and fatigue, weight loss, chronic diarrhea, blindness, excessive fatigue, and CD4 loss. The infected people are susceptible to AIDS. It can cause various cancers, such as Kaposi's sarcoma, cervical cancer, and lymphoma. AIDS can lead to the involvement of neurological problems and may cause early symptoms of central nervous system failure, depression, forgetfulness, lack of concentration, loss of consciousness, apathy, and decreased desire to have sex and may cause confusion, balance disorder, convulsions, advanced dementia, and coma. AIDS can adversely affect all aspects of life, including physical, social, and family life, and even the family members of these patients may be affected. AIDS is a social and medical issue with widespread negative consequences and challenges. It also poses many negative challenges to individuals' and social lives and undermines social and economic growth worldwide, although its negative consequences cannot be reverted. Iranian researchers found that in infected patients, CD4 cell counts of less than 200 cells per microliter were likely to be infections of the lungs, pulmonary tuberculosis, and brain toxoplasmosis, so cell counts should be performed regularly. The researchers found that as predictors of neuronal hormone factors in developing norepinephrine HIV, depression, hopelessness, and avoidant coping significantly reduced CD4 and increased viral load in patients. Also, cortisol hormone correlated with CD4 count. It may not, but it can predict increased viral load. However, there are different conclusions about the impact of exercise on CD4. Researchers have suggested exercise training in health services to improve the mental health of women with AIDS and found that exercise did not affect CD4 count. Considering the importance of HIV and AIDS, this research investigated the effect of cognitive–behavioral group therapy and mindfulness–based cognitive therapy on improving the quality of life and increasing CD4 count in HIV/AIDS patients.
Methods: The present study was quasi–experimental with a pretest–posttest design with a control group. The statistical population includes HIV/AIDS patients referring to Ahvaz Behavioral Counseling Center, Ahvaz City, Iran, in 2019. They were selected by convenience sampling. The sample consisted of three groups of 15 randomly assigned to three groups: cognitive–behavioral therapy, mindfulness–based cognitive therapy, and control group. After implementing a pretest on the cognitive–behavioral and mindfulness groups, the experimental intervention was administered in 8 sessions for one hour and a half one session per week. Quality of Life Scale, CD4 index, and Demographic Factor Questionnaire were used for data collection. Multivariate analysis of covariance was used for data analysis in SPSS.22 software.
Results: The findings showed a statistically significant difference between the three groups of cognitive–behavioral, mindfulness, and control in terms of quality–of–life components (F=8.03, p<0.0001) and CD4 (F=13.85, p<0.0001). These findings suggest that mindfulness therapy is more effective than cognitive–behavioral therapy in improving the quality of life and CD4 of HIV/AIDS patients.
Conclusions: Our study shows that cognitive–behavioral therapy and mindfulness improve the quality of life and CD4 index of AIDS patients, but mindfulness–based cognitive therapy has a greater impact on improving the quality of life and CD4 of AIDS patients.

Keywords: Cognitive–behavioral group therapy, Mindfulness, Quality of life, CD4, HIV/AIDS

Full-Text [PDF 398 kb] (300 Downloads)

Type of Study: Original Research Article | Subject: Psychology

References

1. Rodriguez-Penney AT, Iudicello JE, Riggs PK, Doyle K, Ellis RJ, Letendre SL, et al. Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS Patient Care STDS. 2013;27(1):5–16. [DOI]

2. Taibi DM. Sleep disturbances in persons living with HIV. J Assoc Nurses AIDS Care. 2013;24(1 Suppl):S72–85. [DOI]

3. Buchanan DT, McCurry SM, Eilers K, Applin S, Williams ET, Voss JG. Brief behavioral treatment for insomnia in persons living with HIV. Behav Sleep Med. 2018;16(3):244–58. [DOI]

4. Dianatinasab M, Fararouei M, Padehban V, Dianatinasab A, Alimohamadi Y, Beheshti S, et al. The effect of a 12-week combinational exercise program on CD4 count and mental health among HIV infected women: A randomized control trial. J Exerc Sci Fit. 2018;16(1):21–5. [DOI]

5. Fumaz CR, Gonzalez-Garcia M, Borras X, Muñoz-Moreno JA, Perez-Alvarez N, Mothe B, et al. Psychological stress is associated with high levels of IL-6 in HIV-1 infected individuals on effective combined antiretroviral treatment. Brain Behav Immun. 2012;26(4):568–72. [DOI]

6. Liu H, Zhao M, Ren J, Qi X, Sun H, Qu L, et al. Identifying factors associated with depression among men living with HIV/AIDS and undergoing antiretroviral therapy: a cross-sectional study in Heilongjiang, China. Health Qual Life Outcomes. 2018;16(1):190. [DOI]

7. Low Y, Preud’homme X, Goforth HW, Omonuwa T, Krystal AD. The association of fatigue with depression and insomnia in HIV-seropositive patients: a pilot study. Sleep. 2011;34(12):1723–6. [DOI]

8. Ironson G, O'Cleirigh C, Kumar M, Kaplan L, Balbin E, Kelsch CB, et al. Psychosocial and Neurohormonal predictors of HIV disease progression (CD4 Cells and Viral Load): A 4 year prospective study. AIDS Behav. 2015;19(8):1388–97. [DOI]

9. Khess C, Bhogle B, Ali S, Krishnan A. Chronic insomnia. In: Vyas JN, Ghimire SR. Textbook of postgraduate psychiatry. Jaypee; 2018. pp: 715–28.

10. Oshinaike O, Akinbami A, Ojelabi O, Dada A, Dosunmu A, John Olabode S. Quality of sleep in an HIV population on antiretroviral therapy at an urban tertiary centre in Lagos, Nigeria. Neurol Res Int. 2014;2014:298703. [DOI]

11. Redman KN, Karstaedt AS, Scheuermaier K. Increased CD4 counts, pain and depression are correlates of lower sleep quality in treated HIV positive patients with low baseline CD4 counts. Brain Behav Immun. 2018;69:548–55. [DOI]

12. Kennard B, Brown L, Hawkins L, Risi A, Radcliffe J, Emslie G, et al. Development and implementation of health and wellness CBT for individuals with depression and HIV. Cogn Behav Pract. 2014;21(2):237–46. [DOI]

13. Newcomb ME, Bedoya CA, Blashill AJ, Lerner JA, O'Cleirigh C, Pinkston MM, et al. Description and demonstration of cognitive behavioral therapy to enhance antiretroviral therapy adherence and treat depression in HIV-infected adults. Cogn Behav Pract. 2015;22(4):430–8. [DOI]

14. Safren SA, O'Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012;80(3):404–15. [DOI]

15. Creswell JD, Myers HF, Cole SW, Irwin MR. Mindfulness meditation training effects on CD4+ T lymphocytes in HIV-1 infected adults: a small randomized controlled trial. Brain Behav Immun. 2009;23(2):184–8. [DOI]

16. Cooper V, Clatworthy J, Harding R, Whetham J, Emerge Consortium. Measuring quality of life among people living with HIV: a systematic review of reviews. Health Qual Life Outcomes. 2017;15(1):220. [DOI]

17. Kemmler G, Schmied B, Shetty-Lee A, Zangerle R, Hinterhuber H, Schüssler G, et al. Quality of life of HIV-infected patients: psychometric properties and validation of the German version of the MQOL-HIV. Qual Life Res. 2003;12(8):1037–50. [DOI]

18. Sabouri S, Delavar A, Jabbari H. Quality of life among human immunodeficiency virus-1 infected and human immunodeficiency virus-1/hepatitis C virus co-infected individuals in Iranian patients. Niger Med J. 2016;57(1):49–53. [DOI]

19. SeyedAlinaghi S, Jam S, Foroughi M, Imani A, Mohraz M, Djavid GE, et al. Randomized controlled trial of mindfulness-based stress reduction delivered to human immunodeficiency virus-positive patients in Iran: effects on CD4+ T lymphocyte count and medical and psychological symptoms. Psychosom Med. 2012;74(6):620–7. [DOI]

20. Stewart RE, Chambless DL. Cognitive-behavioral therapy for adult anxiety disorders in clinical practice: a meta-analysis of effectiveness studies. J Consult Clin Psychol. 2009;77(4):595–606. [DOI]

21. Segal ZV, Teasdale JD, Williams JM, Gemar MC. The mindfulness-based cognitive therapy adherence scale: inter-rater reliability, adherence to protocol and treatment distinctiveness. Clinical Psychology & Psychotherapy. 2002;9(2):131–8. [DOI]

22. Hemmati Sabet A, Khalatbari J, Abbas Ghorbani M, Haghighi M, Ahmadpanah M. Group training of stress management vs. group cognitive-behavioral therapy in reducing depression, anxiety and perceived stress among HIV-positive men. Iran J Psychiatry Behav Sci. 2013;7(1):4–8.

23. Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med. 2011;1(1):a006841. [DOI]

24. Parhoon H, Masomzadeh K, Moradi A, Parhoon K, Mirmotahari M. Effectiveness of mindfulness-based Stress reduction (MBSR) on anxiety, depression and post-traumatic stress disorder symptoms in patients with HIV/ AIDS. International Journal of Behavioral Sciences. 2016;10(2):81–6.

25. Gonzalez-Garcia M, Ferrer MJ, Borras X, Muñoz-Moreno JA, Miranda C, Puig J, et al. Effectiveness of mindfulness-based cognitive therapy on the quality of life, emotional status, and CD4 cell count of patients aging with HIV infection. AIDS Behav. 2014;18(4):676–85. [DOI]

26. Yang Y, Liu Y-H, Zhang H-F, Liu J-Y. Effectiveness of mindfulness-based stress reduction and mindfulness-based cognitive therapies on people living with HIV: A systematic review and meta-analysis. International Journal of Nursing Sciences. 2015;2(3):283–94. [DOI]

27. Riley KE, Kalichman S. Mindfulness-based stress reduction for people living with HIV/AIDS: preliminary review of intervention trial methodologies and findings. Health Psychol Rev. 2015;9(2):224–43.

28. Samhkaniyan E, Mahdavi A, Mohamadpour S, Rahmani S. The effectiveness of mindfulness-based cognitive therapy on quality of life and loneliness of women with HIV. J Med Life. 2015;8(Spec Iss 4):107–13. [DOI]